[go: up one dir, main page]

AU2001289735A1 - Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA 1 receptors and/or dopamine D2 receptors - Google Patents

Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA 1 receptors and/or dopamine D2 receptors

Info

Publication number
AU2001289735A1
AU2001289735A1 AU2001289735A AU8973501A AU2001289735A1 AU 2001289735 A1 AU2001289735 A1 AU 2001289735A1 AU 2001289735 A AU2001289735 A AU 2001289735A AU 8973501 A AU8973501 A AU 8973501A AU 2001289735 A1 AU2001289735 A1 AU 2001289735A1
Authority
AU
Australia
Prior art keywords
receptors
hta
dopamine
conjunction
treating diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289735A
Other languages
English (en)
Inventor
Karl-August Ackermann
Gert Bartoszyk
Rudolf Gottschlich
Helmut Prucher
Christoph Seyfried
Christoph Van Amsterdam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2001289735A1 publication Critical patent/AU2001289735A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2001289735A 2000-08-24 2001-07-24 Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA 1 receptors and/or dopamine D2 receptors Abandoned AU2001289735A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10041574A DE10041574A1 (de) 2000-08-24 2000-08-24 Chromenonderivate
DE10041574 2000-08-24
PCT/EP2001/008528 WO2002016354A1 (fr) 2000-08-24 2001-07-24 Derives de chromenone et leur utilisation pour traiter des affections en rapport avec des recepteurs de 5-hta1 et/ ou des recepteurs d2 de dopamine

Publications (1)

Publication Number Publication Date
AU2001289735A1 true AU2001289735A1 (en) 2002-03-04

Family

ID=7653636

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289735A Abandoned AU2001289735A1 (en) 2000-08-24 2001-07-24 Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA 1 receptors and/or dopamine D2 receptors

Country Status (16)

Country Link
US (1) US20040014768A1 (fr)
EP (1) EP1311503A1 (fr)
JP (1) JP2004506733A (fr)
KR (1) KR20030022390A (fr)
CN (1) CN1447807A (fr)
AU (1) AU2001289735A1 (fr)
BR (1) BR0113364A (fr)
CA (1) CA2420206A1 (fr)
CZ (1) CZ2003659A3 (fr)
DE (1) DE10041574A1 (fr)
MX (1) MXPA03001609A (fr)
NO (1) NO20030811L (fr)
PL (1) PL359222A1 (fr)
SK (1) SK2942003A3 (fr)
WO (1) WO2002016354A1 (fr)
ZA (1) ZA200302255B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003007956A1 (fr) 2001-07-20 2003-01-30 Psychogenics, Inc. Traitement des troubles de deficit de l'attention/hyperactivite
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
ATE450041T1 (de) 2004-03-26 2009-12-15 Lg Electronics Inc Aufzeichnungsmedium und verfahren und vorrichtung zum wiedergeben eines auf dem aufzeichnungsmedium aufgezeichneten textuntertitelstroms
RU2378722C2 (ru) 2004-03-26 2010-01-10 ЭлДжи ЭЛЕКТРОНИКС ИНК. Носитель записи, способ и устройство для воспроизведения потоков текстовых субтитров
WO2012087229A1 (fr) * 2010-12-20 2012-06-28 Astrazeneca Ab Dérivé de 2-carboxamide-4-pipérazinyl-benzofurane
CN104059046B (zh) * 2013-03-18 2017-02-08 江苏恩华药业股份有限公司 黄酮类衍生物及其应用
CN116332918B (zh) * 2023-03-17 2025-07-25 遵义医科大学珠海校区 香豆素-喹啉衍生物及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704390A (en) * 1986-02-13 1987-11-03 Warner-Lambert Company Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents
DE4111861A1 (de) * 1991-04-11 1992-10-15 Schwabe Willmar Gmbh & Co Benzopyranone, verfahren zu ihrer herstellung und verwendung

Also Published As

Publication number Publication date
PL359222A1 (en) 2004-08-23
NO20030811D0 (no) 2003-02-21
CN1447807A (zh) 2003-10-08
EP1311503A1 (fr) 2003-05-21
US20040014768A1 (en) 2004-01-22
BR0113364A (pt) 2003-07-15
NO20030811L (no) 2003-02-21
WO2002016354A1 (fr) 2002-02-28
CA2420206A1 (fr) 2003-02-21
KR20030022390A (ko) 2003-03-15
DE10041574A1 (de) 2002-03-07
CZ2003659A3 (cs) 2003-06-18
SK2942003A3 (en) 2003-09-11
MXPA03001609A (es) 2003-06-04
JP2004506733A (ja) 2004-03-04
ZA200302255B (en) 2004-08-16

Similar Documents

Publication Publication Date Title
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
PT1296974E (pt) Derivados 2-cianopirrolidina e sua utilização como medicamentos
HUP0300746A3 (en) Proline derivatives and use thereof as drugs
IL156678A0 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU2002222001A1 (en) 3-arylindole derivatives and their use as CB2 receptor agonists
AU2001282267A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
HUP0301773A3 (en) Apomorphine derivatives and methods for their use
HUP0203961A3 (en) 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicedes
AU4923200A (en) Isothiazolecarboxamides and their use as microbicides
AU2001248365A1 (en) 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
AU2001289735A1 (en) Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA 1 receptors and/or dopamine D2 receptors
AU2001230355A1 (en) Benzoxazole derivatives and their use as pesticides
AU2001235437A1 (en) Isothiazolecarboxylic acid derivatives and their use as microbicides
AU5464901A (en) Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
AU2001235829A1 (en) Mutations in spink5 responsible for netherton's syndrome and atopic diseases
IL155853A0 (en) Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
SI1259515T1 (en) Thienopyridine derivatives and their use as anti-inflammatory agents
AU2002215187A1 (en) S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease
AU2001235364A1 (en) Tetrahydronaphtalene derivatives and their use
AU2003235887A1 (en) Bislactone derivative and use thereof in medicinal composition
AU2001278963A1 (en) Muo-conopeptides and their use as local anesthetics
AU2001228784A1 (en) Inositol derivatives and their pharmaceutical use